Crolius Clayton

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 21% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -79%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Crolius Clayton's trades of DNA X Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US DNA X Inc (SONM)
Transaction date
Sale
Price
142.23
Quantity 38,361 +13.2%
Value US$2,157,773
US DNA X Inc (SONM)
Transaction date
Purchase
Price
455.64
Quantity 63,337 -49.6%
Value US$3,663,283
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-04-25 2025-04-23
US DNA X Inc (SONM)
S Sale
38,361 +13.2%
142.23
US$2,157,773 		38,361 +13.2% 142.23 US$2,157,773
2023-09-18 2023-09-15
US DNA X Inc (SONM)
B Purchase
63,337 -49.6%
455.64
US$3,663,283 		63,337 -49.6% 455.64 US$3,663,283